Medical Care

Global Nucleic Acid Amplification Detection and Diagnostics Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Amplification Detection and Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Amplification Detection and Diagnostics.
The Nucleic Acid Amplification Detection and Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nucleic Acid Amplification Detection and Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic Acid Amplification Detection and Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
BioMerieux SA
BIO-RAD LABORATORIES INC.
THERMO FISHER SCIENTIFIC INC.
Illumina, Inc.
Danaher
QIAGEN
Abbott
Meridian Bioscience, Inc.
F. Hoffmann-La Roche Ltd.
PreAnalytiX
Eiken Chemical
Lucigen
OptiGene
NEB
Quidel Corporation
Promega
Hologic
Ustar
Grifols
Nugen
Segment by Type
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Isothermal Amplification Technology
Direct Nucleic Acid Detection
CRISPR-Cas9
Segment by Application
Hospital and Clinics
Diagnostic Centers
Research Institutes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nucleic Acid Amplification Detection and Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid Amplification Detection and Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Next Generation Sequencing (NGS)
1.2.4 Isothermal Amplification Technology
1.2.5 Direct Nucleic Acid Detection
1.2.6 CRISPR-Cas9
1.3 Market by Application
1.3.1 Global Nucleic Acid Amplification Detection and Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital and Clinics
1.3.3 Diagnostic Centers
1.3.4 Research Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid Amplification Detection and Diagnostics Market Perspective (2020-2031)
2.2 Global Nucleic Acid Amplification Detection and Diagnostics Growth Trends by Region
2.2.1 Global Nucleic Acid Amplification Detection and Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nucleic Acid Amplification Detection and Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Nucleic Acid Amplification Detection and Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Nucleic Acid Amplification Detection and Diagnostics Market Dynamics
2.3.1 Nucleic Acid Amplification Detection and Diagnostics Industry Trends
2.3.2 Nucleic Acid Amplification Detection and Diagnostics Market Drivers
2.3.3 Nucleic Acid Amplification Detection and Diagnostics Market Challenges
2.3.4 Nucleic Acid Amplification Detection and Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid Amplification Detection and Diagnostics Players by Revenue
3.1.1 Global Top Nucleic Acid Amplification Detection and Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Nucleic Acid Amplification Detection and Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Nucleic Acid Amplification Detection and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nucleic Acid Amplification Detection and Diagnostics Revenue
3.4 Global Nucleic Acid Amplification Detection and Diagnostics Market Concentration Ratio
3.4.1 Global Nucleic Acid Amplification Detection and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Amplification Detection and Diagnostics Revenue in 2024
3.5 Global Key Players of Nucleic Acid Amplification Detection and Diagnostics Head office and Area Served
3.6 Global Key Players of Nucleic Acid Amplification Detection and Diagnostics, Product and Application
3.7 Global Key Players of Nucleic Acid Amplification Detection and Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid Amplification Detection and Diagnostics Breakdown Data by Type
4.1 Global Nucleic Acid Amplification Detection and Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Nucleic Acid Amplification Detection and Diagnostics Forecasted Market Size by Type (2026-2031)
5 Nucleic Acid Amplification Detection and Diagnostics Breakdown Data by Application
5.1 Global Nucleic Acid Amplification Detection and Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Nucleic Acid Amplification Detection and Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nucleic Acid Amplification Detection and Diagnostics Market Size (2020-2031)
6.2 North America Nucleic Acid Amplification Detection and Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2020-2025)
6.4 North America Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nucleic Acid Amplification Detection and Diagnostics Market Size (2020-2031)
7.2 Europe Nucleic Acid Amplification Detection and Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2020-2025)
7.4 Europe Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid Amplification Detection and Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Nucleic Acid Amplification Detection and Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nucleic Acid Amplification Detection and Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Nucleic Acid Amplification Detection and Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nucleic Acid Amplification Detection and Diagnostics Market Size (2020-2031)
9.2 Latin America Nucleic Acid Amplification Detection and Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Nucleic Acid Amplification Detection and Diagnostics Introduction
11.1.4 BD Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
11.1.5 BD Recent Development
11.2 BioMerieux SA
11.2.1 BioMerieux SA Company Details
11.2.2 BioMerieux SA Business Overview
11.2.3 BioMerieux SA Nucleic Acid Amplification Detection and Diagnostics Introduction
11.2.4 BioMerieux SA Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
11.2.5 BioMerieux SA Recent Development
11.3 BIO-RAD LABORATORIES INC.
11.3.1 BIO-RAD LABORATORIES INC. Company Details
11.3.2 BIO-RAD LABORATORIES INC. Business Overview
11.3.3 BIO-RAD LABORATORIES INC. Nucleic Acid Amplification Detection and Diagnostics Introduction
11.3.4 BIO-RAD LABORATORIES INC. Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
11.3.5 BIO-RAD LABORATORIES INC. Recent Development
11.4 THERMO FISHER SCIENTIFIC INC.
11.4.1 THERMO FISHER SCIENTIFIC INC. Company Details
11.4.2 THERMO FISHER SCIENTIFIC INC. Business Overview
11.4.3 THERMO FISHER SCIENTIFIC INC. Nucleic Acid Amplification Detection and Diagnostics Introduction
11.4.4 THERMO FISHER SCIENTIFIC INC. Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
11.4.5 THERMO FISHER SCIENTIFIC INC. Recent Development
11.5 Illumina, Inc.
11.5.1 Illumina, Inc. Company Details
11.5.2 Illumina, Inc. Business Overview
11.5.3 Illumina, Inc. Nucleic Acid Amplification Detection and Diagnostics Introduction
11.5.4 Illumina, Inc. Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
11.5.5 Illumina, Inc. Recent Development
11.6 Danaher
11.6.1 Danaher Company Details
11.6.2 Danaher Business Overview
11.6.3 Danaher Nucleic Acid Amplification Detection and Diagnostics Introduction
11.6.4 Danaher Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
11.6.5 Danaher Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Details
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN Nucleic Acid Amplification Detection and Diagnostics Introduction
11.7.4 QIAGEN Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
11.7.5 QIAGEN Recent Development
11.8 Abbott
11.8.1 Abbott Company Details
11.8.2 Abbott Business Overview
11.8.3 Abbott Nucleic Acid Amplification Detection and Diagnostics Introduction
11.8.4 Abbott Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
11.8.5 Abbott Recent Development
11.9 Meridian Bioscience, Inc.
11.9.1 Meridian Bioscience, Inc. Company Details
11.9.2 Meridian Bioscience, Inc. Business Overview
11.9.3 Meridian Bioscience, Inc. Nucleic Acid Amplification Detection and Diagnostics Introduction
11.9.4 Meridian Bioscience, Inc. Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
11.9.5 Meridian Bioscience, Inc. Recent Development
11.10 F. Hoffmann-La Roche Ltd.
11.10.1 F. Hoffmann-La Roche Ltd. Company Details
11.10.2 F. Hoffmann-La Roche Ltd. Business Overview
11.10.3 F. Hoffmann-La Roche Ltd. Nucleic Acid Amplification Detection and Diagnostics Introduction
11.10.4 F. Hoffmann-La Roche Ltd. Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
11.10.5 F. Hoffmann-La Roche Ltd. Recent Development
11.11 PreAnalytiX
11.11.1 PreAnalytiX Company Details
11.11.2 PreAnalytiX Business Overview
11.11.3 PreAnalytiX Nucleic Acid Amplification Detection and Diagnostics Introduction
11.11.4 PreAnalytiX Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
11.11.5 PreAnalytiX Recent Development
11.12 Eiken Chemical
11.12.1 Eiken Chemical Company Details
11.12.2 Eiken Chemical Business Overview
11.12.3 Eiken Chemical Nucleic Acid Amplification Detection and Diagnostics Introduction
11.12.4 Eiken Chemical Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
11.12.5 Eiken Chemical Recent Development
11.13 Lucigen
11.13.1 Lucigen Company Details
11.13.2 Lucigen Business Overview
11.13.3 Lucigen Nucleic Acid Amplification Detection and Diagnostics Introduction
11.13.4 Lucigen Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
11.13.5 Lucigen Recent Development
11.14 OptiGene
11.14.1 OptiGene Company Details
11.14.2 OptiGene Business Overview
11.14.3 OptiGene Nucleic Acid Amplification Detection and Diagnostics Introduction
11.14.4 OptiGene Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
11.14.5 OptiGene Recent Development
11.15 NEB
11.15.1 NEB Company Details
11.15.2 NEB Business Overview
11.15.3 NEB Nucleic Acid Amplification Detection and Diagnostics Introduction
11.15.4 NEB Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
11.15.5 NEB Recent Development
11.16 Quidel Corporation
11.16.1 Quidel Corporation Company Details
11.16.2 Quidel Corporation Business Overview
11.16.3 Quidel Corporation Nucleic Acid Amplification Detection and Diagnostics Introduction
11.16.4 Quidel Corporation Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
11.16.5 Quidel Corporation Recent Development
11.17 Promega
11.17.1 Promega Company Details
11.17.2 Promega Business Overview
11.17.3 Promega Nucleic Acid Amplification Detection and Diagnostics Introduction
11.17.4 Promega Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
11.17.5 Promega Recent Development
11.18 Hologic
11.18.1 Hologic Company Details
11.18.2 Hologic Business Overview
11.18.3 Hologic Nucleic Acid Amplification Detection and Diagnostics Introduction
11.18.4 Hologic Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
11.18.5 Hologic Recent Development
11.19 Ustar
11.19.1 Ustar Company Details
11.19.2 Ustar Business Overview
11.19.3 Ustar Nucleic Acid Amplification Detection and Diagnostics Introduction
11.19.4 Ustar Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
11.19.5 Ustar Recent Development
11.20 Grifols
11.20.1 Grifols Company Details
11.20.2 Grifols Business Overview
11.20.3 Grifols Nucleic Acid Amplification Detection and Diagnostics Introduction
11.20.4 Grifols Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
11.20.5 Grifols Recent Development
11.21 Nugen
11.21.1 Nugen Company Details
11.21.2 Nugen Business Overview
11.21.3 Nugen Nucleic Acid Amplification Detection and Diagnostics Introduction
11.21.4 Nugen Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
11.21.5 Nugen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Polymerase Chain Reaction (PCR)
Table 3. Key Players of Next Generation Sequencing (NGS)
Table 4. Key Players of Isothermal Amplification Technology
Table 5. Key Players of Direct Nucleic Acid Detection
Table 6. Key Players of CRISPR-Cas9
Table 7. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Nucleic Acid Amplification Detection and Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Nucleic Acid Amplification Detection and Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Nucleic Acid Amplification Detection and Diagnostics Market Share by Region (2020-2025)
Table 11. Global Nucleic Acid Amplification Detection and Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Nucleic Acid Amplification Detection and Diagnostics Market Share by Region (2026-2031)
Table 13. Nucleic Acid Amplification Detection and Diagnostics Market Trends
Table 14. Nucleic Acid Amplification Detection and Diagnostics Market Drivers
Table 15. Nucleic Acid Amplification Detection and Diagnostics Market Challenges
Table 16. Nucleic Acid Amplification Detection and Diagnostics Market Restraints
Table 17. Global Nucleic Acid Amplification Detection and Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Nucleic Acid Amplification Detection and Diagnostics Market Share by Players (2020-2025)
Table 19. Global Top Nucleic Acid Amplification Detection and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Amplification Detection and Diagnostics as of 2024)
Table 20. Ranking of Global Top Nucleic Acid Amplification Detection and Diagnostics Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Nucleic Acid Amplification Detection and Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Nucleic Acid Amplification Detection and Diagnostics, Headquarters and Area Served
Table 23. Global Key Players of Nucleic Acid Amplification Detection and Diagnostics, Product and Application
Table 24. Global Key Players of Nucleic Acid Amplification Detection and Diagnostics, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nucleic Acid Amplification Detection and Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Nucleic Acid Amplification Detection and Diagnostics Revenue Market Share by Type (2020-2025)
Table 28. Global Nucleic Acid Amplification Detection and Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Nucleic Acid Amplification Detection and Diagnostics Revenue Market Share by Type (2026-2031)
Table 30. Global Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Nucleic Acid Amplification Detection and Diagnostics Revenue Market Share by Application (2020-2025)
Table 32. Global Nucleic Acid Amplification Detection and Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Nucleic Acid Amplification Detection and Diagnostics Revenue Market Share by Application (2026-2031)
Table 34. North America Nucleic Acid Amplification Detection and Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Nucleic Acid Amplification Detection and Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Nucleic Acid Amplification Detection and Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Nucleic Acid Amplification Detection and Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Nucleic Acid Amplification Detection and Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Nucleic Acid Amplification Detection and Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 49. BD Company Details
Table 50. BD Business Overview
Table 51. BD Nucleic Acid Amplification Detection and Diagnostics Product
Table 52. BD Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025) & (US$ Million)
Table 53. BD Recent Development
Table 54. BioMerieux SA Company Details
Table 55. BioMerieux SA Business Overview
Table 56. BioMerieux SA Nucleic Acid Amplification Detection and Diagnostics Product
Table 57. BioMerieux SA Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025) & (US$ Million)
Table 58. BioMerieux SA Recent Development
Table 59. BIO-RAD LABORATORIES INC. Company Details
Table 60. BIO-RAD LABORATORIES INC. Business Overview
Table 61. BIO-RAD LABORATORIES INC. Nucleic Acid Amplification Detection and Diagnostics Product
Table 62. BIO-RAD LABORATORIES INC. Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025) & (US$ Million)
Table 63. BIO-RAD LABORATORIES INC. Recent Development
Table 64. THERMO FISHER SCIENTIFIC INC. Company Details
Table 65. THERMO FISHER SCIENTIFIC INC. Business Overview
Table 66. THERMO FISHER SCIENTIFIC INC. Nucleic Acid Amplification Detection and Diagnostics Product
Table 67. THERMO FISHER SCIENTIFIC INC. Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025) & (US$ Million)
Table 68. THERMO FISHER SCIENTIFIC INC. Recent Development
Table 69. Illumina, Inc. Company Details
Table 70. Illumina, Inc. Business Overview
Table 71. Illumina, Inc. Nucleic Acid Amplification Detection and Diagnostics Product
Table 72. Illumina, Inc. Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025) & (US$ Million)
Table 73. Illumina, Inc. Recent Development
Table 74. Danaher Company Details
Table 75. Danaher Business Overview
Table 76. Danaher Nucleic Acid Amplification Detection and Diagnostics Product
Table 77. Danaher Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025) & (US$ Million)
Table 78. Danaher Recent Development
Table 79. QIAGEN Company Details
Table 80. QIAGEN Business Overview
Table 81. QIAGEN Nucleic Acid Amplification Detection and Diagnostics Product
Table 82. QIAGEN Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025) & (US$ Million)
Table 83. QIAGEN Recent Development
Table 84. Abbott Company Details
Table 85. Abbott Business Overview
Table 86. Abbott Nucleic Acid Amplification Detection and Diagnostics Product
Table 87. Abbott Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025) & (US$ Million)
Table 88. Abbott Recent Development
Table 89. Meridian Bioscience, Inc. Company Details
Table 90. Meridian Bioscience, Inc. Business Overview
Table 91. Meridian Bioscience, Inc. Nucleic Acid Amplification Detection and Diagnostics Product
Table 92. Meridian Bioscience, Inc. Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025) & (US$ Million)
Table 93. Meridian Bioscience, Inc. Recent Development
Table 94. F. Hoffmann-La Roche Ltd. Company Details
Table 95. F. Hoffmann-La Roche Ltd. Business Overview
Table 96. F. Hoffmann-La Roche Ltd. Nucleic Acid Amplification Detection and Diagnostics Product
Table 97. F. Hoffmann-La Roche Ltd. Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025) & (US$ Million)
Table 98. F. Hoffmann-La Roche Ltd. Recent Development
Table 99. PreAnalytiX Company Details
Table 100. PreAnalytiX Business Overview
Table 101. PreAnalytiX Nucleic Acid Amplification Detection and Diagnostics Product
Table 102. PreAnalytiX Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025) & (US$ Million)
Table 103. PreAnalytiX Recent Development
Table 104. Eiken Chemical Company Details
Table 105. Eiken Chemical Business Overview
Table 106. Eiken Chemical Nucleic Acid Amplification Detection and Diagnostics Product
Table 107. Eiken Chemical Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025) & (US$ Million)
Table 108. Eiken Chemical Recent Development
Table 109. Lucigen Company Details
Table 110. Lucigen Business Overview
Table 111. Lucigen Nucleic Acid Amplification Detection and Diagnostics Product
Table 112. Lucigen Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025) & (US$ Million)
Table 113. Lucigen Recent Development
Table 114. OptiGene Company Details
Table 115. OptiGene Business Overview
Table 116. OptiGene Nucleic Acid Amplification Detection and Diagnostics Product
Table 117. OptiGene Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025) & (US$ Million)
Table 118. OptiGene Recent Development
Table 119. NEB Company Details
Table 120. NEB Business Overview
Table 121. NEB Nucleic Acid Amplification Detection and Diagnostics Product
Table 122. NEB Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025) & (US$ Million)
Table 123. NEB Recent Development
Table 124. Quidel Corporation Company Details
Table 125. Quidel Corporation Business Overview
Table 126. Quidel Corporation Nucleic Acid Amplification Detection and Diagnostics Product
Table 127. Quidel Corporation Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025) & (US$ Million)
Table 128. Quidel Corporation Recent Development
Table 129. Promega Company Details
Table 130. Promega Business Overview
Table 131. Promega Nucleic Acid Amplification Detection and Diagnostics Product
Table 132. Promega Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025) & (US$ Million)
Table 133. Promega Recent Development
Table 134. Hologic Company Details
Table 135. Hologic Business Overview
Table 136. Hologic Nucleic Acid Amplification Detection and Diagnostics Product
Table 137. Hologic Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025) & (US$ Million)
Table 138. Hologic Recent Development
Table 139. Ustar Company Details
Table 140. Ustar Business Overview
Table 141. Ustar Nucleic Acid Amplification Detection and Diagnostics Product
Table 142. Ustar Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025) & (US$ Million)
Table 143. Ustar Recent Development
Table 144. Grifols Company Details
Table 145. Grifols Business Overview
Table 146. Grifols Nucleic Acid Amplification Detection and Diagnostics Product
Table 147. Grifols Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025) & (US$ Million)
Table 148. Grifols Recent Development
Table 149. Nugen Company Details
Table 150. Nugen Business Overview
Table 151. Nugen Nucleic Acid Amplification Detection and Diagnostics Product
Table 152. Nugen Revenue in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025) & (US$ Million)
Table 153. Nugen Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
Table 157. Authors List of This Report


List of Figures
Figure 1. Nucleic Acid Amplification Detection and Diagnostics Picture
Figure 2. Global Nucleic Acid Amplification Detection and Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nucleic Acid Amplification Detection and Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. Polymerase Chain Reaction (PCR) Features
Figure 5. Next Generation Sequencing (NGS) Features
Figure 6. Isothermal Amplification Technology Features
Figure 7. Direct Nucleic Acid Detection Features
Figure 8. CRISPR-Cas9 Features
Figure 9. Global Nucleic Acid Amplification Detection and Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Nucleic Acid Amplification Detection and Diagnostics Market Share by Application: 2024 VS 2031
Figure 11. Hospital and Clinics Case Studies
Figure 12. Diagnostic Centers Case Studies
Figure 13. Research Institutes Case Studies
Figure 14. Others Case Studies
Figure 15. Nucleic Acid Amplification Detection and Diagnostics Report Years Considered
Figure 16. Global Nucleic Acid Amplification Detection and Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Nucleic Acid Amplification Detection and Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Nucleic Acid Amplification Detection and Diagnostics Market Share by Region: 2024 VS 2031
Figure 19. Global Nucleic Acid Amplification Detection and Diagnostics Market Share by Players in 2024
Figure 20. Global Top Nucleic Acid Amplification Detection and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Amplification Detection and Diagnostics as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Nucleic Acid Amplification Detection and Diagnostics Revenue in 2024
Figure 22. North America Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Nucleic Acid Amplification Detection and Diagnostics Market Share by Country (2020-2031)
Figure 24. United States Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Nucleic Acid Amplification Detection and Diagnostics Market Share by Country (2020-2031)
Figure 28. Germany Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Nucleic Acid Amplification Detection and Diagnostics Market Share by Region (2020-2031)
Figure 36. China Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Nucleic Acid Amplification Detection and Diagnostics Market Share by Country (2020-2031)
Figure 44. Mexico Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Market Share by Country (2020-2031)
Figure 48. Turkey Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Nucleic Acid Amplification Detection and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. BD Revenue Growth Rate in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
Figure 52. BioMerieux SA Revenue Growth Rate in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
Figure 53. BIO-RAD LABORATORIES INC. Revenue Growth Rate in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
Figure 54. THERMO FISHER SCIENTIFIC INC. Revenue Growth Rate in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
Figure 55. Illumina, Inc. Revenue Growth Rate in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
Figure 56. Danaher Revenue Growth Rate in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
Figure 57. QIAGEN Revenue Growth Rate in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
Figure 58. Abbott Revenue Growth Rate in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
Figure 59. Meridian Bioscience, Inc. Revenue Growth Rate in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
Figure 60. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
Figure 61. PreAnalytiX Revenue Growth Rate in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
Figure 62. Eiken Chemical Revenue Growth Rate in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
Figure 63. Lucigen Revenue Growth Rate in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
Figure 64. OptiGene Revenue Growth Rate in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
Figure 65. NEB Revenue Growth Rate in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
Figure 66. Quidel Corporation Revenue Growth Rate in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
Figure 67. Promega Revenue Growth Rate in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
Figure 68. Hologic Revenue Growth Rate in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
Figure 69. Ustar Revenue Growth Rate in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
Figure 70. Grifols Revenue Growth Rate in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
Figure 71. Nugen Revenue Growth Rate in Nucleic Acid Amplification Detection and Diagnostics Business (2020-2025)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies